HPV 28 Genotyping Detection Kit-Cowingene|HPV Detection,PCR Testing

The Cowingene HPV 28 Genotyping Detection Kit represents a cutting-edge solution in the field of human papilloma virus (HPV) detection by PCR. Designed for precision and efficiency, this kit offers a comprehensive approach to identifying 28 high-risk HPV subtypes, making it an essential tool in cervical cancer screening and molecular diagnostics. This article explores the product's features, advantages, technical specifications, application scenarios, and the company's background, supported by authoritative references from the National Institute of Standards and Technology (NIST).

Image: Cowingene HPV 28 Genotyping Detection Kit

Understanding the Importance of HPV Detection

Human papillomavirus (HPV) is the most common sexually transmitted infection, with over 100 identified strains. Among these, 14 are classified as high-risk for causing cervical cancer, the second most common cancer in women globally. Early detection of high-risk HPV subtypes is critical for preventing disease progression. The Cowingene HPV 28 Genotyping Detection Kit leverages polymerase chain reaction (PCR) technology to identify 28 HPV subtypes, including 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, and 83. This extensive coverage ensures a robust screening platform for clinical and research applications.

Image: HPV Detection by PCR

Key Features of the Cowingene HPV 28 Genotyping Detection Kit

The Cowingene HPV 28 Genotyping Detection Kit is engineered to deliver exceptional accuracy, speed, and reliability. Below are its core features:

• Comprehensive Subtype Coverage: Detects 28 high-risk HPV subtypes, ensuring broad-spectrum screening for cervical cancer risk assessment.
• High Sensitivity and Specificity: Utilizes advanced PCR technology to minimize false positives and negatives, critical for clinical decision-making.
• Flexible Sample Types: Validated for cervical swabs, urine, and self-collected vaginal samples, enhancing accessibility for diverse patient populations.
• Streamlined Workflow: Designed for ease of use in laboratory settings, reducing hands-on time and minimizing contamination risks.
• Compliance with Standards: Adheres to international standards for molecular diagnostics, ensuring reproducibility and regulatory compliance.

Image: HPV Detection by PCR

Technical Specifications

The Cowingene HPV 28 Genotyping Detection Kit is backed by rigorous technical specifications that highlight its performance and reliability:

Parameter	Details
Target Subtypes	6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Sample Types	Cervical swab, Urine, Self-collected vaginal
Detection Method	Real-time PCR
Limit of Detection (LOD)	100 copies/mL (varies by subtype)
Run Time	Approximately 2.5 hours
Storage Conditions	-20°C for 12 months (unopened); 4°C for 1 month (opened)

Advantages of the Cowingene HPV 28 Genotyping Detection Kit

The Cowingene HPV 28 Genotyping Detection Kit offers several advantages that make it a preferred choice for laboratories and healthcare providers:

• Enhanced Diagnostic Accuracy: The kit’s ability to distinguish between 28 HPV subtypes reduces the risk of misdiagnosis, enabling targeted treatment plans.
• Cost-Effective Screening: By identifying multiple subtypes in a single test, it minimizes the need for repeated testing, reducing overall healthcare costs.
• Scalability: Suitable for high-throughput laboratories, the kit supports large-scale screening programs without compromising quality.
• Regulatory Compliance: Developed in accordance with global standards for molecular diagnostics, ensuring trust and acceptance in clinical settings.

Application Scenarios

The Cowingene HPV 28 Genotyping Detection Kit is ideal for various applications, including:

• Cervical Cancer Screening: Detects high-risk HPV subtypes in cervical samples, aiding in early intervention and prevention.
• Research and Development: Supports studies on HPV prevalence, vaccine efficacy, and disease progression.
• Public Health Initiatives: Facilitates large-scale screening programs in underserved communities, improving access to healthcare.
• Diagnostic Laboratories: Provides a reliable tool for routine HPV testing, ensuring consistent and accurate results.

About Taizhou Cowingene Biotech Co., Ltd.

Founded in 2015, Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and infectious disease testing. Based in Taizhou, China, the company is committed to developing innovative solutions that address global health challenges. With a focus on research and development, Cowingene has established itself as a trusted provider of high-quality diagnostic kits and reagents.

As a pioneer in the field of human papilloma virus (HPV) detection by PCR, Cowingene combines advanced technology with rigorous quality control to ensure its products meet the highest standards. The Cowingene HPV 28 Genotyping Detection Kit exemplifies the company’s dedication to precision and reliability, making it a valuable asset for laboratories and healthcare professionals worldwide.

Authoritative Citations and References

The development and validation of molecular diagnostic tools like the Cowingene HPV 28 Genotyping Detection Kit are guided by international standards and research. The National Institute of Standards and Technology (NIST) plays a pivotal role in establishing measurement standards that ensure the accuracy and consistency of such technologies. According to NIST, "precise measurements are essential for the development of reliable diagnostic tools, as they underpin the reproducibility and validity of test results" (NIST).

Additionally, the World Health Organization (WHO) emphasizes the importance of HPV testing in cervical cancer prevention, stating that "molecular detection methods, such as PCR-based assays, are critical for identifying high-risk HPV infections and guiding clinical management" (WHO). These references underscore the significance of tools like the Cowingene kit in advancing public health initiatives.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit stands out as a reliable and efficient solution for HPV detection. With its comprehensive subtype coverage, high sensitivity, and flexibility in sample types, it addresses the critical need for accurate and accessible cervical cancer screening. Backed by the expertise of Taizhou Cowingene Biotech Co., Ltd. and adherence to international standards, this kit is a testament to the power of innovation in molecular diagnostics.

For more information about the Cowingene HPV 28 Genotyping Detection Kit or to explore other products from Taizhou Cowingene Biotech Co., Ltd., visit their official website today.

References

• National Institute of Standards and Technology (NIST)
• World Health Organization (WHO)